Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Spanish eTIPS for Early Therapy in Perinatal Stroke (eTIPS-ES)

18 de maio de 2026 atualizado por: University of Castilla-La Mancha

Spanish eTIPS: Translation, Cross-Cultural Adaptation, and Pilot Randomized Feasibility Study of Early Therapy in Perinatal Stroke for Spanish-Speaking Families

This study adapts and evaluates the Spanish version of eTIPS, an early home-based therapy program for infants at risk of unilateral cerebral palsy after perinatal stroke. The project has three parts: translation and cultural adaptation of the original materials, a pilot randomized feasibility study comparing eTIPS with usual care, and a qualitative study exploring family experiences, barriers, and facilitators to using the program at home.

In the first part, the study team will translate and culturally adapt the eTIPS materials for Spanish-speaking families, review them with experts, and test whether the content is clear, relevant, and usable. In the second part, families with infants diagnosed with perinatal stroke or at high risk of unilateral cerebral palsy will be assigned to either the eTIPS program or usual clinical care to assess recruitment, retention, adherence, safety, acceptability, and preliminary effects on infant motor development and family outcomes. In the third part, caregivers in the intervention group will take part in interviews to better understand how the program fits into daily life and what could improve future implementation.

Visão geral do estudo

Descrição detalhada

This is a mixed-methods study designed to translate, culturally adapt, and evaluate the Spanish version of eTIPS, an early, parent-delivered therapy program originally developed for infants with perinatal stroke and risk of unilateral cerebral palsy. The project follows a staged approach with three linked phases: Phase I, translation and cross-cultural adaptation of the intervention materials; Phase II, a pilot randomized feasibility study; and Phase III, a qualitative study of family experiences and implementation.

Phase I will include forward translation, back-translation, expert review, and feedback from caregivers and professionals to ensure semantic, conceptual, and cultural equivalence of the Spanish materials. Phase II will randomize eligible infants to eTIPS or usual care, with the intervention delivered by caregivers in the home environment and supported by the research team. Outcomes in this phase will focus on feasibility and process measures such as eligibility, recruitment, consent, retention, adherence, usability, safety, and fidelity, as well as exploratory infant and caregiver outcomes.

The infant assessments may include measures of hand function, motor development, neurological status, and stroke-related outcomes, while caregiver outcomes may include well-being, stress, competence, and bonding. Phase III will use semi-structured interviews and thematic analysis to explore how caregivers experience the intervention in everyday routines, including perceived benefits, barriers, facilitators, and suggestions for improvement. The results will be used to refine the Spanish eTIPS program and inform the design of a future definitive multicenter trial.

Tipo de estudo

Intervencional

Inscrição (Estimado)

20

Estágio

  • Não aplicável

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Filho

Aceita Voluntários Saudáveis

Não

Descrição

Inclusion Criteria:

  • Infants with confirmed unilateral perinatal stroke diagnosis by neuroimaging, identified within first 3 months of life
  • Age at recruitment ≤3 months postnatal (intervention starts when clinically stable, maximum term-equivalent age)
  • Written informed consent from parents/legal guardians

Exclusion Criteria:

  • Known progressive neurodegenerative disorder or severe medical comorbidity preventing participation (e.g., ventilation-dependent respiratory failure)
  • Extensive bilateral intracerebral lesion making lateralized intervention irrelevant
  • Concurrent participation in another clinical trial with interfering treatment

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Solteiro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: eTIPS Intervention
Participants assigned to this arm will receive the Spanish-adapted eTIPS program, a parent-delivered, home-based early intervention for infants with perinatal stroke or risk of unilateral cerebral palsy. Families will receive training, adapted materials, and ongoing support to integrate lateralized therapeutic activities into daily routines from enrollment until corrected age 6 months.
Parent-delivered, home-based early therapy for infants with perinatal stroke or risk of unilateral cerebral palsy. Families receive the Spanish-adapted eTIPS materials, training, and ongoing support to integrate lateralized therapeutic activities into daily routines from enrollment until corrected age 6 months. The intervention is delivered alongside usual clinical care
Comparador Ativo: Usual Care
Participants assigned to this arm will receive usual clinical care according to local practice, including standard neonatal, neurological, and rehabilitation follow-up. This arm serves as the comparator for feasibility, acceptability, and exploratory outcome assessment
Standard neonatal, neurological, and rehabilitation follow-up according to local clinical practice. Includes routine pediatric neurology monitoring, periodic neurological evaluations to track motor development and detect early signs of unilateral cerebral palsy, and referral to pediatric rehabilitation with physiotherapy sessions (1 session/week or biweekly, 30-45 minutes) focused on mobilizations, muscle tone control, joint range maintenance, general sensory stimulation, and basic postural guidelines.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Recruitment Rate
Prazo: From identification to enrollment (baseline)
Proportion of eligible infants identified in neonatology/pediatric neurology who accept participation. Success criterion: ≥70% acceptance rate
From identification to enrollment (baseline)
Retention Rate
Prazo: 6 months (end of intervention)
Percentage of families completing the 6-month follow-up. Success criterion: ≥80% retention
6 months (end of intervention)
Adherence Rate
Prazo: Daily/weekly during 6 months
Days per week and minutes per week of practice recorded in digital diary/app. Success criterion: ≥70% practice days
Daily/weekly during 6 months

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Usability (SUS Score)
Prazo: Post-intervention (6 months)
System Usability Scale (SUS) score for materials and platform. Target: ≥70 points
Post-intervention (6 months)
Safety
Prazo: Throughout 6 months
Adverse events or incidents related to intervention (excessive fatigue, persistent rejection, feeding worsening)
Throughout 6 months
Parental Satisfaction
Prazo: Post-Intervention (6 months)
Likert-scale questionnaire on experience, confidence gained, and recommendation of program
Post-Intervention (6 months)
Fidelity
Prazo: Monthly during 6 months
Professional observation of correct eTIPS technique application during scheduled visits
Monthly during 6 months

Outras medidas de resultado

Medida de resultado
Descrição da medida
Prazo
Hand Assessment for Infants (HAI)
Prazo: Baseline, 3 months, 6 months, 12 months
Video-based observational assessment of unimanual and bimanual hand function
Baseline, 3 months, 6 months, 12 months
Infant Motor Profile (IMP)
Prazo: Baseline, 3 months, 6 months
Structured observation of fine and gross motor patterns
Baseline, 3 months, 6 months
Paediatric Stroke Outcome Measure (PSOM)
Prazo: Baseline, 3 months, 6 months
Neurological and functional sequelae monitoring post-stroke
Baseline, 3 months, 6 months
Bayley Scales of Infant Development (BSID-IV)
Prazo: Baseline, 3 months, 6 months, 12 months
Standardized assessment of cognitive, motor and socio-emotional development in children from 1 to 42 months.
Baseline, 3 months, 6 months, 12 months
Hammersmith Infant Neurological Examination (HINE)
Prazo: Baseline, 3 months, 6 months
Standardized neurological assessment for infants 2-24 months evaluating motor and neurological development
Baseline, 3 months, 6 months
Parenting Sense of Competence (PSOC)
Prazo: Baseline, 3 months, 6 months
Questionnaire measuring parental perception of competence in child care and education
Baseline, 3 months, 6 months
Warwick-Edinburgh Mental Well-Being Scale (WEMWBS)
Prazo: Baseline, 3 months, 6 months
Brief scale measuring psychological and emotional well-being in primary caregivers
Baseline, 3 months, 6 months
Family Empowerment Scale
Prazo: Baseline, 6 months
Measures family perception of empowerment in caring for and supporting child with special needs
Baseline, 6 months
Edinburgh Postnatal Depression Scale (EPDS)
Prazo: Baseline, 3 months, 6 months
10-item self-report screening for postpartum depressive symptoms (cut-off ≥10/12). Spanish validated
Baseline, 3 months, 6 months
Parenting Stress Index - Short Form (PSI-SF)
Prazo: Baseline, 3 months, 6 months
36-item measure of parental stress across 3 subscales: Parental Distress, Parent-Child Dysfunctional Interaction, Difficult Child
Baseline, 3 months, 6 months
Postpartum Bonding Questionnaire (PBQ)
Prazo: Baseline, 3 months, 6 months
25-item questionnaire assessing mother-infant bonding quality. Detects rejection, anger, infantification (cut-off ≥12 factor 1)
Baseline, 3 months, 6 months

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

1 de setembro de 2026

Conclusão Primária (Estimado)

31 de julho de 2028

Conclusão do estudo (Estimado)

31 de dezembro de 2028

Datas de inscrição no estudo

Enviado pela primeira vez

18 de maio de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

18 de maio de 2026

Primeira postagem (Real)

26 de maio de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

26 de maio de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

18 de maio de 2026

Última verificação

1 de maio de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • Spanish eTIPS

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Descrição do plano IPD

No plan to share individual participant data (IPD). Data will be stored securely at Universidad de Castilla-La Mancha following Spanish and EU data protection regulations (RGPD/LOPDGDD). Aggregate results will be published in peer-reviewed journals.

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever